Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, …
Biotechnology
US, Cambridge [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Seres Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Seres Therapeutics, Inc. has no acquisition track records yet.